Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human CD20 Recombinant Antibody(Ocaratuzumab)

Product Information
Catalog Number YR1285
Product Name Anti-Human CD20 Recombinant Antibody(Ocaratuzumab)
Molecular Name Ocaratuzumab
Alias Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab
CAS Number 1169956-08-4
Target CD20[Homo sapiens]
Isotype IgG1 Kappa
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Applications Neut, ELISA, IF, IP, FuncS, FCM, ICC
Buffer PBS, pH7.5
Background Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity FcγRIIIa allotypes.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.